Results 151 to 160 of about 235,698 (344)

Atrial fibrillation and flutter as global drivers of heart failure: Burden and longitudinal trends over three decades

ESC Heart Failure, EarlyView.
Abstract Aims The study aims to comprehensively evaluate the global burden of heart failure attributable to atrial fibrillation (AF) and atrial flutter (AFL) from 1990 to 2021. Methods Using data from the Global Burden of Disease Study 2021, we estimated the prevalence and years lived with disability (YLDs) of heart failure attributable to AF/AFL ...
Yabin Liu, Jingsi Duan, Yue Wang, Nicola Luigi Bragazzi, Mengying Huang, Huimin Chen, Haijiang Dai, Cheng Ni   +7 more
wiley   +1 more source

Portal vein thrombosis after laparoscopic splenectomy: an ongoing clinical challenge. [PDF]

, 2005
ObjectivesPortal vein thrombosis (PVT) following open splenectomy is a potentially lethal complication with an incidence of up to 6%. The objective of this report is to describe our management of a recent laparoscopic case, discuss current therapies, and
Kee, Stephen T, Krummel, Thomas M, Mallory, Baird, Miniati, Douglas N, Padidar, Arash M   +4 more
core   +2 more sources

Anticoagulation

This chapter aims to summarize the most relevant aspects of anticoagulants. Initially, a brief review of the physiology is given in order to understand at which step of coagulation each anticoagulant acts. Later, the main indications and contraindications will be discussed, as well as the considerations that should be taken into account before starting
Hernando, Nieto, Raquel, Bengelloun, García, Adrián Karim, Roviralta, Abildúa, Beatriz, Maria, de La Paz Sarabia Velasco,, Sanz, Lozano, María, Criado, Alonso, Elena   +5 more
openaire   +2 more sources

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source

Activated Clotting Times versus Protocol Anticoagulation Management [PDF]

, 1983
James P. Dearing, David M. Bartles, Martha R. Stroud, Robert M. Sade   +3 more
openalex   +1 more source

A unique case of protein-losing enteropathy as a complication of segmental arterial mediolysis

Journal of Vascular Surgery Cases and Innovative Techniques
Protein-losing enteropathy (PLE) can be caused by erosive and nonerosive gastrointestinal diseases, mesenteric lymphatic obstruction, and increased central venous pressure. Superior mesenteric artery pathology (SMAP), including dissection or occlusion is
Nedaa Skeik, MD, FACC, FACP, FSVM, RPVI, Rebecca Windschitl, MD, Naureen Qadri, MD, Jesse Manunga, MD   +3 more
doaj  

A central-flow, low-profile, leaflet-deforming mitral valve prosthesis free of prolonged anticoagulation requirements

, 1969
K. Wm. Edmark, Willis Hill, George I. Thomas, Thomas W. Jones   +3 more
openalex   +1 more source

Dialysis without Anticoagulation [PDF]

, 1983
S. Hathiwala
openalex   +1 more source

Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification

ESC Heart Failure, EarlyView.
Abstract Clinical endpoint classification (CEC)—that is, evaluation of clinical events using pre‐defined criteria—is commonly conducted in clinical trial operations to ensure systematic and consistent assessment of endpoints needed to assess the intervention's safety and efficacy.
Veraprapas Kittipibul, Harriette G.C. Van Spall, William Schuyler Jones, Marat Fudim, Robert J. Mentz, Kevin Anstrom, Bertram Pitt, Patrice Desvigne‐Nickens, Jerome L. Fleg, Camilla Hage, Stefan James, Claes Held, Lars Lund, Adam DeVore   +13 more
wiley   +1 more source

Impact of self-reported race on Villalta Scale postthrombotic syndrome scores and correlation with venous disease-specific quality of life: an exploratory analysis of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis Trial

Research and Practice in Thrombosis and Haemostasis
Background: The Villalta Scale (VS) to diagnose postthrombotic syndrome (PTS) consists of 5 patient-reported leg symptoms and 6 clinician-rated leg signs. It is unknown how the scale performs across racial groups.
James Shih, MD, Chu-Shu Gu, PhD, Suresh Vedantham, MD, John Kaufman, MD, Susan R. Kahn, MD   +4 more
doaj